Search

Your search keyword '"Schirmacher, Peter"' showing total 2,874 results

Search Constraints

Start Over You searched for: Author "Schirmacher, Peter" Remove constraint Author: "Schirmacher, Peter"
2,874 results on '"Schirmacher, Peter"'

Search Results

1. Die Pathologie im Rahmen des europäischen und nationalen Medizinprodukterechts: Betrieb, Anwendung und Eigenherstellung von In-vitro-Diagnostika

5. Proteomic profiling reveals CEACAM6 function in driving gallbladder cancer aggressiveness through integrin receptor, PRKCD and AKT/ERK signaling

6. Dynamic YAP expression in the non-parenchymal liver cell compartment controls heterologous cell communication

8. Benchmarking whole exome sequencing in the German network for personalized medicine

14. Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer Cells

15. Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice

16. Steatohepatitic hepatocellular Carcinoma:A new approach to classifying morphological subtypes of hepatocellular carcinoma

17. Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial

19. Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients

24. High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency–Associated Genomic Instability in Ovarian Cancer

29. Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset

30. Deep Learning–Enabled Diagnosis of Liver Adenocarcinoma

34. An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets

35. Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas

38. Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing

39. Framework and baseline examination of the German National Cohort (NAKO)

41. Struktur und Inhalt der EU-IVDR: Bestandsaufnahme und Implikationen für die Pathologie

43. Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?

46. Severe acute liver disease in adults: Contemporary role of histopathology.

47. Durable Response With Sequential Tyrosine Kinase Inhibitor Treatment in a Patient With ROS1 Fusion–Positive Pancreatic Adenocarcinoma: A Case Report

49. Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma

50. Molecular testing for the clinical diagnosis of fibrolamellar carcinoma

Catalog

Books, media, physical & digital resources